InvestSMART

Cellmid Limited (ASX: CDY) - Announcements

- Current share price for CDY : $0.056

ASX company news and announcements for Cellmid Limited (CDY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cellmid Limited (CDY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cellmid Limited (CDY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cellmid Limited (CDY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Results of Completed CK3000 Diagnostic Study 18 Dec 2013 11:26AM $0.032 $0.056 risen by 75%
- Capital Raising of $2 million 11 Dec 2013 8:50AM $0.031 $0.056 risen by 80.65%
- Trading Halt 9 Dec 2013 8:45AM $0.033 $0.056 risen by 69.70%
- Appendix 4C - quarterly 23 Oct 2013 9:22AM $0.041 $0.056 risen by 36.59%
- Key Antibody Patent Granted in Japan 18 Oct 2013 9:28AM $0.033 $0.056 risen by 69.70%
- Key European Patent for Anti-Midkine Antibodies Granted 8 Oct 2013 9:17AM $0.029 $0.056 risen by 93.10%
- R&D Tax Refund Received 4 Oct 2013 8:55AM $0.028 $0.056 risen by 100%
- Midkine antibodies effective in cancer 3 Oct 2013 9:26AM $0.030 $0.056 risen by 86.67%
- Cellmid Signs Major Japanese Distribution Agreement 20 Sep 2013 9:01AM $0.030 $0.056 risen by 86.67%
- Appendix 4E and Preliminary Final Report 28 Aug 2013 5:01PM $0.029 $0.056 risen by 93.10%
- Cellmid Received Pacific Edge Milestone Shares 1 Aug 2013 1:22PM $0.031 $0.056 risen by 80.65%
- Cellmid Collaborates on Early Diagnosis of Colorectal Cancer 29 Jul 2013 9:10AM $0.031 $0.056 risen by 80.65%
- Appendix 4C - quarterly 26 Jul 2013 11:02AM $0.031 $0.056 risen by 80.65%
- Fujikura Exercises Option To License Cellmid Diagnostics 18 Jul 2013 9:05AM $0.036 $0.056 risen by 55.56%
- Advangen Acquisition 8 May 2013 8:54AM $0.033 $0.056 risen by 69.70%
- Trading Halt 6 May 2013 9:17AM $0.025 $0.056 risen by 124%
- Appendix 4C - quarterly 22 Apr 2013 3:19PM $0.033 $0.056 risen by 69.70%
- Cellmid Diagnostic Licenses Update 26 Mar 2013 9:56AM $0.039 $0.056 risen by 43.59%
- Cellmid Completes $2M Placement 13 Mar 2013 9:17AM $0.045 $0.056 risen by 24.44%
- Trading Halt 11 Mar 2013 9:35AM $0.050 $0.056 risen by 12%
- Response to ASX Price Query 8 Mar 2013 5:13PM $0.050 $0.056 risen by 12%
- Response to ASX Price Query 27 Feb 2013 1:11PM $0.027 $0.056 risen by 107.41%
- Appendix 4D and Half Year Accounts 15 Feb 2013 3:22PM $0.025 $0.056 risen by 124%
- Cellmid Signs Midkine Diagnostic Agreement 11 Feb 2013 9:24AM $0.021 $0.056 risen by 166.67%
- Appendix 4C - quarterly 29 Jan 2013 10:00AM $0.021 $0.056 risen by 166.67%

451 - 475 of 530 results

Page 19 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.